In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...